The Fast Team Uses the Worm

Posted on August 19, 2020March 16, 2023 by adamlaing

In a play on the adage “the early bird gets the worm”, Newormics describes how Perlara accelerated the search for a repurposed drug to treat an orphan disease using the Read more about The Fast Team Uses the Worm[…]

vivoVerse Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office

Posted on August 5, 2020May 3, 2023 by adamlaing

Patent covers the vivoChip® invention that vivoVerse licensed for use in immobilization of C. elegans for high resolution imaging. AUSTIN, TX. August 5, 2020 – vivoVerse (formerly operating as Newormics), a developer of Read more about vivoVerse Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office[…]

vivoVerse awarded SBIR Phase II grant from the NIMH

Posted on July 8, 2020September 11, 2023 by adamlaing

vivoVerse (formerly operating as Newormics) is excited to announce it has been awarded a $2.25M Phase II SBIR grant from the National Institutes of Health/National Institute of Mental Health (NIMH) Read more about vivoVerse awarded SBIR Phase II grant from the NIMH[…]

COVID-19 UPDATE

Posted on March 27, 2020November 16, 2022 by adamlaing

Dear Customers, Colleagues, and Collaborators: At Newormics, we recognize that combating the spread of this new virus requires a global community effort. As we navigate this uncharted landscape together with Read more about COVID-19 UPDATE[…]

Newormics launches new vivoChips for early stage worms

Posted on October 14, 2019August 19, 2020 by adamlaing

Early larval stages of C. elegans (L1 to L3 and Dauer) have always been among the hardest to immobilize and image successfully, due to their tiny size and difficulties with Read more about Newormics launches new vivoChips for early stage worms[…]

DDNews features Newormics in their latest issue in a special report on drug screening

Posted on August 10, 2019August 20, 2020 by adamlaing

The research of Newormics is featured in a special report in the July 2019 issue of DDNews in an article titled “Phenotypic finery: Microscopy meets the molecular in the search Read more about DDNews features Newormics in their latest issue in a special report on drug screening[…]

Newormics at the 2019 UK C. elegans meeting

Posted on July 30, 2019August 19, 2020 by adamlaing

Newormics is exhibiting at the 2019 UK C. elegans meeting at Imperial College London on September 16th. Come meet us and view our latest imaging solutions there. We will also Read more about Newormics at the 2019 UK C. elegans meeting[…]

Newormics awarded an SBIR Phase I grant from the NIEHS

Posted on July 9, 2019November 9, 2019 by adamlaing

Newormics was awarded an SBIR Phase I grant from the National Institute of Environmental Health Sciences (NIEHS) for the project “A Large-Scale Microfluidics Imaging Platform for High-Throughput Toxicity Testing using Read more about Newormics awarded an SBIR Phase I grant from the NIEHS[…]

Newormics at the 2019 International C. elegans Conference

Posted on June 20, 2019August 18, 2020 by adamlaing

Newormics is exhibiting at the 22nd International C. elegans Conference at UCLA, Los Angeles from 20th June – 24th June. Come and meet the team here at our booth.

Newormics selected for the NIH I-Corps

Posted on June 18, 2019December 11, 2019 by adamlaing

Newormics was selected for the NIH I-Corps April-June 2019 cohort. Over the course of the I-Corps program, the team had conversations with over 100 stakeholders in the field. This helped Read more about Newormics selected for the NIH I-Corps[…]